Costing of services under National Tuberculosis Elimination Program at public health facilities of northern India. 2022. Forthcoming
Kumar D, Prinja S.
Financing Comprehensive Immunization Services in Lao PDR: A fiscal space analysis from a public policy perspective.
Bahuguna P, Masaki E, Jeet G, Prinja S.
Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone ReceptorPositive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women.
Gupta N, Gupta D, Dixit J, Mehra N, Singh A, Krishnamurthy MN, Jyani G, Rajsekhar K, Kalaiyarasi JP, Roy PS, Malik PS.
COVID-19 Management: The Vaccination Drive in India.
Purohit N, Chugh Y, Bahuguna P, Prinja S.
Economic Impact And SafetY of Same-Day Discharge Following Percutaneous Coronary Intervention: A Tertiary-Care Centre Experience From Northern India (EASY-SDD).
N Kaur, R Vijayvergiya, S Prinja, J Dixit, SK Sahoo, G Kasinadhuni. E
Among the Urban Poor Population in India.
Singh, L. M., Siddhanta, A., Singh, A. K., Prinja, S., Sharma, A., Sikka, H., & Goswami, L.
Health system readiness for roll out of the Ayushman Bharat Health and Wellnes Centres-Early experiences from Punjab State.
Brar S, Purohit N, Singh G, Prinja S, Kaur M, Lakshmi PV.
Cost Effectiveness of Bevacizumab Plus Chemotherapy for the Treatment of Advanced and Metastatic Cervical Cancer in India?A Model-Based Economic Analysis.
Gupta N, Nehra P, Chauhan AS, Mehra N, Singh A, Krishnamurthy MN, Rajsekhar K, Kalaiyarasi JP, Roy PS, Malik PS, Mathew A
Financial Burden in Families of Children with West Syndrome.
Raithatha D, Sahu JK, Bhanudeep S, Saini L, Prinja S, Bharti B, Madaan P, Rana SK, Negi S. F
Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set. Value Health.
Jyani G, Sharma A, Prinja S, Kar SS, Trivedi M, Patro BK, Goyal A, Purba FD, Finch AP, Rajsekar K, Raman S